IMV INC. Inactive Instrument
IMV Inc. Share Price Toronto S.E.
Equities
IMV
CA44974L3011
Biotechnology & Medical Research
| Sales 2021 | - | Sales 2022 | - | Capitalization | 30.6M 41.83M 2.55B |
|---|---|---|---|---|---|
| Net income 2021 | -36M -49.21M -3B | Net income 2022 | -38M -51.94M -3.17B | EV / Sales 2021 | - |
| Net cash position 2021 | 18.96M 25.92M 1.58B | Net Debt 2022 | 7.67M 10.49M 640M | EV / Sales 2022 | - |
| P/E ratio 2021 |
-2.47
x | P/E ratio 2022 |
-0.53
x | Employees | 63 |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 99.93% |
More Fundamentals
* Assessed data
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
Andrew Hall
CEO | Chief Executive Officer | - | 10/20/10 |
Brittany Davison
DFI | Director of Finance/CFO | - | - |
| Chief Operating Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 58 | 01/20/01 | |
Kyle Kuvalanka
BRD | Director/Board Member | 56 | 01/21/01 |
Markus Warmuth
BRD | Director/Board Member | 53 | 06/18/06 |
IMV Inc. is a Canada-based company. The Company has no business operations.
| 1st Jan change | Capi. | |
|---|---|---|
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
